Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia:: is this the real target?

被引：12

作者：

Malagola, M ^{[1
]}

Martinelli, G ^{[1
]}

Rondoni, M ^{[1
]}

Paolini, S ^{[1
]}

Gaitani, S ^{[1
]}

Arpinati, M ^{[1
]}

Piccaluga, PP ^{[1
]}

Amabile, M ^{[1
]}

Basi, C ^{[1
]}

Ottaviani, E ^{[1
]}

Candoni, A ^{[1
]}

Gottardi, E ^{[1
]}

Cilloni, D ^{[1
]}

Bocchia, M ^{[1
]}

Saglio, G ^{[1
]}

Lauria, F ^{[1
]}

Fanin, R ^{[1
]}

Visani, G ^{[1
]}

Marré, MC ^{[1
]}

Maderna, M ^{[1
]}

Rancati, F ^{[1
]}

Vinaccia, V ^{[1
]}

Russo, D ^{[1
]}

Baccarani, M ^{[1
]}

机构：

[1] Policlin S Orsola, Inst Hematol & Med Oncol L & A Seragnoli, I-40138 Bologna, Italy

来源：

BLOOD | 2005年 / 105卷 / 02期

关键词：

D O I：

10.1182/blood-2004-08-3088

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：904 / 904

页数：1

共 50 条

[21] Remission in a patient with c-kit positive refractory acute myelogenous leukemia after imatinib treatment
Yildirim, Z
Grant, BW
Liu, XLS
Branda, RR
Cushman, M
Holmes, CE
Tindle, BH
BLOOD, 2002, 100 (11) : 266B - 266B
[22] Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate
Brave, Michael
Goodman, Vicki
Kaminskas, Edvardas
Farrell, Ann
Timmer, William
Pope, Sarah
Harapanhalli, Ravi
Saber, Haleh
Morse, David
Bullock, Julie
Men, Angela
Noory, Carol
Ramchandani, Roshni
Kenna, Leslie
Booth, Brian
Gobburu, Joga
Jiang, Xiaoping
Sridhara, Rajeshwari
Justice, Robert
Pazdur, Richard
CLINICAL CANCER RESEARCH, 2008, 14 (02) : 352 - 359
[23] Chronic myeloid leukemia arising from acute myeloid leukemia: response to imatinib mesylate with favorable outcome
Xu, Xiao-Hua
Huang, Lian-Sheng
Yang, Jing
Yu, Teng
Tong, Jie-Feng
Yuan, Xiang-Gui
Zhao, Xiao-Ying
LEUKEMIA & LYMPHOMA, 2013, 54 (01) : 195 - 197
[24] Spotlight on Imatinib Mesylate in Chronic Myeloid Leukemia
Monique P. Curran
Katherine F. Croom
Karen L. Goa
BioDrugs, 2004, 18 : 207 - 210
[25] Spotlight on imatinib mesylate in chronic myeloid leukemia
Curran, MP
Croom, KF
Goa, KL
BIODRUGS, 2004, 18 (03) : 207 - 210
[26] Therapy with Imatinib Mesylate for Chronic Myeloid Leukemia
Arora, Brijesh
Kumar, Lalit
Kumari, Mamta
Sharma, Atul
Wadhawa, Jyoti
Kochupillai, V
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2005, 26 (02) : 5 - +
[27] Chronic myeloid leukemia in children and adolescents: results of treatment with imatinib mesylate
Lakshmaiah, K. C.
Bhise, Rohan
Purohit, Samit
Abraham, Linu J.
Lokanatha, D.
Suresh, T. M.
Appaji, L.
Arunakumari, B. S.
Govindbabu, K.
LEUKEMIA & LYMPHOMA, 2012, 53 (12) : 2430 - 2433
[28] The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia
Eskazan, Ahmet Emre
Elverdi, Tugrul
Yalniz, Fevzi Firat
Salihoglu, Ayse
Ar, Muhlis Cem
Aydin, Seniz Ongoren
Baslar, Zafer
Aydin, Yildiz
Tuzuner, Nukhet
Ozbek, Ugur
Soysal, Teoman
LEUKEMIA & LYMPHOMA, 2014, 55 (12) : 2935 - 2937
[29] Imatinib mesylate - The new gold standard for treatment of chronic myeloid leukemia
Peggs, K
Mackinnon, S
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (11): : 1048 - 1050
[30] Treatment modalities in hematology: Imatinib mesylate as therapy for chronic myeloid leukemia
A. Gratwohl
International Journal of Hematology, 2002, 76 : 149 - 149

← 1 2 3 4 5 →